We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Bayer’s remorse

24 January 2020 By Ed Cropley, Aimee Donnellan

The German chemicals group may spend $10 billion compensating alleged cancer victims of its acquisition’s Roundup weed killer. That would be better than CEO Werner Baumann’s worst fears. But it barely makes his ill-starred $66 billion deal look any better.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)